These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 37560311)

  • 21. Bacteroides vulgatus Ameliorates Lipid Metabolic Disorders and Modulates Gut Microbial Composition in Hyperlipidemic Rats.
    Xu M; Lan R; Qiao L; Lin X; Hu D; Zhang S; Yang J; Zhou J; Ren Z; Li X; Liu G; Liu L; Xu J
    Microbiol Spectr; 2023 Feb; 11(1):e0251722. PubMed ID: 36625637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Intestinal Fatty Acid-Enteroendocrine Interplay, Emerging Roles for Olfactory Signaling and Serotonin Conjugates.
    Meijerink J
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33807994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary Patterns Affect the Gut Microbiome-The Link to Risk of Cardiometabolic Diseases.
    Tindall AM; Petersen KS; Kris-Etherton PM
    J Nutr; 2018 Sep; 148(9):1402-1407. PubMed ID: 30184227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary Bile Acids and Short Chain Fatty Acids in the Colon: A Focus on Colonic Microbiome, Cell Proliferation, Inflammation, and Cancer.
    Zeng H; Umar S; Rust B; Lazarova D; Bordonaro M
    Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30862015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The roles of microbial products in the development of colorectal cancer: a review.
    Fang Y; Yan C; Zhao Q; Xu J; Liu Z; Gao J; Zhu H; Dai Z; Wang D; Tang D
    Bioengineered; 2021 Dec; 12(1):720-735. PubMed ID: 33618627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health.
    Kandalgaonkar MR; Kumar V; Vijay-Kumar M
    Physiol Rep; 2024 Jun; 12(12):e16114. PubMed ID: 38886098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short chain fatty acids: Microbial metabolites for gut-brain axis signalling.
    O'Riordan KJ; Collins MK; Moloney GM; Knox EG; Aburto MR; Fülling C; Morley SJ; Clarke G; Schellekens H; Cryan JF
    Mol Cell Endocrinol; 2022 Apr; 546():111572. PubMed ID: 35066114
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiota and short chain fatty acids partially mediate the beneficial effects of inulin on metabolic disorders in obese ob/ob mice.
    Guo J; Zhang M; Wang H; Li N; Lu Z; Li L; Hui S; Xu H
    J Food Biochem; 2022 May; 46(5):e14063. PubMed ID: 35128673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intersection of the Gut Microbiome and Circadian Rhythms in Metabolism.
    Frazier K; Chang EB
    Trends Endocrinol Metab; 2020 Jan; 31(1):25-36. PubMed ID: 31677970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
    Massey W; Brown JM
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of Microbiota-Derived Metabolites in Colorectal Cancer.
    Duizer C; de Zoete MR
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
    Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
    Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the therapeutic application of short-chain fatty acids (SCFAs): An updated review.
    Rauf A; Khalil AA; Rahman UU; Khalid A; Naz S; Shariati MA; Rebezov M; Urtecho EZ; de Albuquerque RDDG; Anwar S; Alamri A; Saini RK; Rengasamy KRR
    Crit Rev Food Sci Nutr; 2022; 62(22):6034-6054. PubMed ID: 33703960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolite interactions between host and microbiota during health and disease: Which feeds the other?
    Zhang Y; Chen R; Zhang D; Qi S; Liu Y
    Biomed Pharmacother; 2023 Apr; 160():114295. PubMed ID: 36709600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration.
    Zheng Z; Wang B
    Front Immunol; 2021; 12():775526. PubMed ID: 34956204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut microbiota alterations and dietary modulation in childhood malnutrition - The role of short chain fatty acids.
    Pekmez CT; Dragsted LO; Brahe LK
    Clin Nutr; 2019 Apr; 38(2):615-630. PubMed ID: 29496274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring gut microbial metabolites as key players in inhibition of cancer progression: Mechanisms and therapeutic implications.
    Yin T; Zhang X; Xiong Y; Li B; Guo D; Sha Z; Lin X; Wu H
    Microbiol Res; 2024 Nov; 288():127871. PubMed ID: 39137590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids.
    Ahmad F; Saha P; Singh V; Wahid M; Mandal RK; Nath Mishra B; Fagoonee S; Haque S
    Food Chem; 2023 Jun; 410():135320. PubMed ID: 36610090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Microbiota and Cardiovascular Disease.
    Witkowski M; Weeks TL; Hazen SL
    Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Regulation of Microbiota and Tissue Response.
    Xu Z; Chen M; Ng SC
    Gastroenterol Clin North Am; 2024 Sep; 53(3):399-412. PubMed ID: 39068002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.